Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumothorax-II

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Atelectasis II: Pathophysiology

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Genetics of Iron Metabolism on Biochemical and Hematological Phenotypes of Heart Failure.

International journal of molecular sciences·2026

Same author

Hypertensive Heart Disease and HFpEF: What We Have Learned in the Last Decade.

The American journal of cardiology·2026

Same author

Coronary Artery Disease in Heart Failure With Preserved Ejection Fraction.

The American journal of cardiology·2025

Same author

Impact of vitamin D supplementation in the prognosis of patients with SARS-CoV2 pneumonia admitted to the intensive care unit - a randomized controlled trial.

Frontiers in immunology·2025

Same author

Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2025

Same author

The Immunomodulatory Activity of High Doses of Vitamin D in Critical Care Patients with Severe SARS-CoV-2 Pneumonia-A Randomized Controlled Trial.

Nutrients·2025

Search research articles

Related Experiment Videos

[Pulmonary abcess, a revision].

Ana Moura Gonçalves¹, Luiz Menezes Falcão, Luciano Ravara

¹Interna do Internato Complementar de Medicina Interna, no Hospital de Santa Maria, Lisboa, Portugal. anapmgoncalves@gmail.com

Revista Portuguesa De Pneumologia

|February 13, 2008

Summary

Lung abscesses are lung infections causing tissue destruction. Risk factors include chronic lung disease, aspiration, and altered mental status, with antimicrobial resistance posing a challenge.

Area of Science:

Pulmonology
Infectious Diseases
Microbiology

Context:

Lung abscesses are cavitating lesions resulting from microbial infections.
Certain patient populations face elevated risks, including those with chronic lung disease, bronchial obstruction, or aspiration risks.

Purpose:

To review the bacteriological characteristics, diagnosis, therapy, and prognosis of lung abscesses.
To address the growing concern of antimicrobial resistance in treating these infections.

Summary:

Lung abscesses are characterized by necrotic debris within cavitating lesions, primarily caused by microbial agents.
Key risk factors encompass chronic lung conditions, bronchial obstruction (e.g., from cancer), aspiration events (linked to alcoholism or altered mental status), and anatomical or physiological abnormalities of the upper aerodigestive tract.

Related Experiment Videos

The review covers essential aspects including bacteriology, diagnostic approaches, therapeutic strategies, and prognostic indicators, while also acknowledging the challenge of antimicrobial resistance.

Impact:

Informing clinicians about high-risk patient groups for early detection and intervention.
Highlighting the importance of understanding bacteriological profiles for effective treatment selection.
Emphasizing the need for strategies to combat antimicrobial resistance in lung abscess management.